119 related articles for article (PubMed ID: 18208870)
1. Evidence for association of chromosome 10 open reading frame (C10orf27) gene polymorphisms and multiple sclerosis.
Goertsches R; Baranzini SE; Morcillo C; Nos C; Camiña M; Oksenberg JR; Montalban X; Comabella M
Mult Scler; 2008 Apr; 14(3):412-4. PubMed ID: 18208870
[TBL] [Abstract][Full Text] [Related]
2. Genetic association of CASP8 polymorphisms with primary progressive multiple sclerosis.
Camiña-Tato M; Fernández M; Morcillo-Suárez C; Navarro A; Julià E; Edo MC; Montalban X; Comabella M
J Neuroimmunol; 2010 May; 222(1-2):70-5. PubMed ID: 20363033
[TBL] [Abstract][Full Text] [Related]
3. Genetic differences between primary progressive and relapsing-remitting multiple sclerosis: The impact of immune-related genes variability.
Kiselev I; Bashinskaya V; Baulina N; Kozin M; Popova E; Boyko A; Favorova O; Kulakova O
Mult Scler Relat Disord; 2019 Apr; 29():130-136. PubMed ID: 30711878
[TBL] [Abstract][Full Text] [Related]
4. An investigation of polymorphisms in the 4q1 3.3-21.1 CXC chemokine gene cluster for association with multiple sclerosis in Australians.
Bugeja MJ; Booth DR; Bennetts BH; Heard RN; Stewart GJ
Mult Scler; 2006 Dec; 12(6):710-22. PubMed ID: 17262998
[TBL] [Abstract][Full Text] [Related]
5. Gene expression analysis of relapsing-remitting, primary progressive and secondary progressive multiple sclerosis.
Ratzer R; Søndergaard HB; Christensen JR; Börnsen L; Borup R; Sørensen PS; Sellebjerg F
Mult Scler; 2013 Dec; 19(14):1841-8. PubMed ID: 24085340
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-10 promoter polymorphisms in patients with multiple sclerosis.
Myhr KM; Vågnes KS; Marøy TH; Aarseth JH; Nyland HI; Vedeler CA
J Neurol Sci; 2002 Oct; 202(1-2):93-7. PubMed ID: 12220699
[TBL] [Abstract][Full Text] [Related]
7. Lack of replication of KIF1B gene in an Italian primary progressive multiple sclerosis cohort.
Martinelli-Boneschi F; Esposito F; Scalabrini D; Fenoglio C; Rodegher ME; Brambilla P; Colombo B; Ghezzi A; Capra R; Collimedaglia L; Coniglio G; De Riz M; Serpente M; Cantoni C; Scarpini E; Martinelli V; Galimberti D; Comi G
Eur J Neurol; 2010 May; 17(5):740-5. PubMed ID: 20067515
[TBL] [Abstract][Full Text] [Related]
8. Influence of CCR5 delta32 polymorphism on multiple sclerosis susceptibility and disease course.
Silversides JA; Heggarty SV; McDonnell GV; Hawkins SA; Graham CA
Mult Scler; 2004 Apr; 10(2):149-52. PubMed ID: 15124759
[TBL] [Abstract][Full Text] [Related]
9. Global transcriptome profiling of mild relapsing-remitting versus primary progressive multiple sclerosis.
Koch MW; Ilnytskyy Y; Golubov A; Metz LM; Yong VW; Kovalchuk O
Eur J Neurol; 2018 Apr; 25(4):651-658. PubMed ID: 29316044
[TBL] [Abstract][Full Text] [Related]
10. Role of genetic susceptibility variants in predicting clinical course in multiple sclerosis: a cohort study.
Pan G; Simpson S; van der Mei I; Charlesworth JC; Lucas R; Ponsonby AL; Zhou Y; Wu F; Taylor BV
J Neurol Neurosurg Psychiatry; 2016 Nov; 87(11):1204-1211. PubMed ID: 27559181
[TBL] [Abstract][Full Text] [Related]
11. Genetic association between polymorphisms in the ADAMTS14 gene and multiple sclerosis.
Goertsches R; Comabella M; Navarro A; Perkal H; Montalban X
J Neuroimmunol; 2005 Jul; 164(1-2):140-7. PubMed ID: 15913795
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms of apolipoprotein E and Japanese patients with multiple sclerosis.
Niino M; Kikuchi S; Fukazawa T; Yabe I; Tashiro K
Mult Scler; 2003 Aug; 9(4):382-6. PubMed ID: 12926843
[TBL] [Abstract][Full Text] [Related]
13. Single nucleotide polymorphisms in the FOXP3 gene are associated with increased risk of relapsing-remitting multiple sclerosis.
Eftekharian MM; Sayad A; Omrani MD; Ghannad MS; Noroozi R; Mazdeh M; Mirfakhraie R; Movafagh A; Roshanaei G; Azimi T; Inoko H; Taheri M
Hum Antibodies; 2016; 24(3-4):85-90. PubMed ID: 27792007
[TBL] [Abstract][Full Text] [Related]
14. CXCL10 haplotypes and multiple sclerosis: association and correlation with clinical course.
Galimberti D; Scalabrini D; Fenoglio C; Comi C; De Riz M; Venturelli E; Lovati C; Mariani C; Monaco F; Bresolin N; Scarpini E
Eur J Neurol; 2007 Feb; 14(2):162-7. PubMed ID: 17250724
[TBL] [Abstract][Full Text] [Related]
15. Allelic expression and interleukin-2 polymorphisms in multiple sclerosis.
Matesanz F; Fedetz M; Collado-Romero M; Fernández O; Guerrero M; Delgado C; Alcina A
J Neuroimmunol; 2001 Sep; 119(1):101-5. PubMed ID: 11525806
[TBL] [Abstract][Full Text] [Related]
16. Genetic analysis of SLC11A1 polymorphisms in multiple sclerosis patients.
Comabella M; Altet L; Peris F; Villoslada P; Sánchez A; Montalban X
Mult Scler; 2004 Dec; 10(6):618-20. PubMed ID: 15584484
[TBL] [Abstract][Full Text] [Related]
17. Histamine-N-methyl transferase polymorphism and risk for multiple sclerosis.
García-Martín E; Martínez C; Benito-León J; Calleja P; Díaz-Sánchez M; Pisa D; Alonso-Navarro H; Ayuso-Peralta L; Torrecilla D; Agúndez JA; Jiménez-Jiménez FJ
Eur J Neurol; 2010 Feb; 17(2):335-8. PubMed ID: 19538200
[TBL] [Abstract][Full Text] [Related]
18. Increase in CCR5 Delta32/Delta32 genotype in multiple sclerosis.
Pulkkinen K; Luomala M; Kuusisto H; Lehtimäki T; Saarela M; Jalonen TO; Elovaara I
Acta Neurol Scand; 2004 May; 109(5):342-7. PubMed ID: 15080861
[TBL] [Abstract][Full Text] [Related]
19. The p150 subunit of dynactin (DCTN1) gene in multiple sclerosis.
Münch C; Meyer R; Linke P; Meyer T; Ludolph AC; Haas J; Hemmer B
Acta Neurol Scand; 2007 Oct; 116(4):231-4. PubMed ID: 17824900
[TBL] [Abstract][Full Text] [Related]
20. The cannabinoid receptor 1 gene (CNR1) and multiple sclerosis: an association study in two case-control groups from Spain.
Ramil E; Sánchez AJ; González-Pérez P; Rodríguez-Antigüedad A; Gómez-Lozano N; Ortiz P; Arroyo R; De las Heras V; Vilches C; García-Merino A
Mult Scler; 2010 Feb; 16(2):139-46. PubMed ID: 20007426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
